BPH outpatient prescription medicine sales in South Korea 2016, by age group

This statistic shows the sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group. In 2016, the BPH medication sales for patients aged between 70 and 79 years amounted to over 92 billion South Korean won.

Sales value of outpatient prescription drugs for benign prostatic hyperplasia (BPH) in South Korea in 2016, by age group

Sales value in billion South Korean won
--
--
--
--
--
--
Exclusive Premium statistic

You need a Premium Account for unlimited access.

  • Full access to 1m statistics

  • Incl. source references

  • Available to download in PNG, PDF, XLS format

Premium Account

only $59 / month *
*Duration: 12 months, billed annually, single license

Access to this and all other statistics on 80,000 topics from

$708 / Year

Show detailed source information?
Register for free
Already a member?
Log in
Sources

Release date

February 2018

Region

South Korea

Survey time period

2016

Supplementary notes

Note: 1,000 South Korean won equal 0.93 U.S. dollars and 0.78 euros (as of May 2018).
Figures have been rounded.

Statista Accounts: Access All Statistics. Starting from $708 / Year
Basic Account
Get to know the platform

You only have access to basic statistics.
This statistic is not included in your account!

Premium Account
Your perfect start with Statista
  • Instant access to 1m statistics
  • Download in XLS, PDF & PNG format
  • Detailed references

$59 / Month *

Corporate Account
Full access

Corporate solution including all features.

* All products require an annual contract.
   Prices do not include sales tax.

Statistics on "Top pharmaceutical drugs"

Statista Accounts: Access All Statistics. Starting from $708 / Year
Learn more about how Statista can support your business.